You are here » Home » Companies » Company Overview » Beryl Drugs Ltd

Beryl Drugs Ltd.

BSE: 524606 Sector: Health care
NSE: N.A. ISIN Code: INE415H01017
BSE 00:00 | 30 Nov 10.19 0.48
(4.94%)
OPEN

10.19

HIGH

10.19

LOW

9.71

NSE 05:30 | 01 Jan Beryl Drugs Ltd
OPEN 10.19
PREVIOUS CLOSE 9.71
VOLUME 1791
52-Week high 19.30
52-Week low 5.18
P/E
Mkt Cap.(Rs cr) 5
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 10.19
CLOSE 9.71
VOLUME 1791
52-Week high 19.30
52-Week low 5.18
P/E
Mkt Cap.(Rs cr) 5
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Beryl Drugs Ltd. (BERYLDRUGS) - Company History

Beryl Drugs Ltd is engaged in the manufacture sale and export of branded generic pharmaceutical formulations in India and internationally. It offers I.V.fluids and a range of small and large volume injectables. The company also provides a range of eye/ear drops veterinary products and injections. It sells its products through its sales and distribution network. In addition the company offers research and development as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore India.Beryl Drugs Ltd was incorporated as a public limited company on August 24 1993. The company has taken over the running business of M/s Flora and Fauna Remedies on December 15 1993. The shares of Beryl Drugs were listed on M.P. Stock Exchange Bombay Stock Exchange and Ahmedabad Stock Exchange.Beryl has emerged into a global network of pharmaceutical manufacturing research and development contract manufacturing services and veterinary products. The manufacturing facilities of the company are in compliance with WHO GMP specifications.The company owns brands like BERI-CEF injection F-Neuron Amplicillin INJ P-Mol Biprox B-Flox and many more.The company has received ISO 9001:2000 certification for its quality management.

.